U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT06810635) titled 'Polyphenol Metabotypes in People with Diabetes Type 2' on Nov. 06, 2024.

Brief Summary: This cross-sectional study seeks to characterize the overall polyphenol metabotype in patients with T2DM in comparison to age-matched individuals without diabetes. Additionally, the study aims to identify factors that influence the polyphenol metabotype (transit time and gut microbial capacity to degrade polyphenols in particular).

Study Start Date: Jan. 31

Study Type: OBSERVATIONAL

Condition: Type 2 Diabetes Mellitus (T2DM)

Intervention: DIETARY_SUPPLEMENT: Oral Polyphenol Challenge Test / PPPIL

Patients will receive a so-called oral polyp...